Cargando…

New Avenues for the Treatment of Huntington’s Disease

Huntington’s disease (HD) is a neurodegenerative disorder caused by a CAG expansion in the HD gene. The disease is characterized by neurodegeneration, particularly in the striatum and cortex. The first symptoms usually appear in mid-life and include cognitive deficits and motor disturbances that pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Amy, Lalonde, Kathryn, Truesdell, Aaron, Gomes Welter, Priscilla, Brocardo, Patricia S., Rosenstock, Tatiana R., Gil-Mohapel, Joana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394361/ https://www.ncbi.nlm.nih.gov/pubmed/34445070 http://dx.doi.org/10.3390/ijms22168363

Ejemplares similares

Beyond Motor Deficits: Environmental Enrichment Mitigates Huntington’s Disease Effects in YAC128 Mice
por: Plácido, Evelini, et al.
Publicado: (2023)

Temporal Characterization of Behavioral and Hippocampal Dysfunction in the YAC128 Mouse Model of Huntington’s Disease
por: de Paula Nascimento-Castro, Cristine, et al.
Publicado: (2022)

Antidepressant Effects of Probucol on Early-Symptomatic YAC128 Transgenic Mice for Huntington's Disease
por: de Paula Nascimento-Castro, Cristine, et al.
Publicado: (2018)

Hippocampal Neurogenesis Levels Predict WATERMAZE Search Strategies in the Aging Brain
por: Gil-Mohapel, Joana, et al.
Publicado: (2013)

In Pursuit of Healthy Aging: Effects of Nutrition on Brain Function
por: Melzer, Thayza Martins, et al.
Publicado: (2021)

SUMO-modifying Huntington’s disease
por: Soares, Ericks S., et al.
Publicado: (2022)

Effects of Ethanol Exposure during Distinct Periods of Brain Development on Hippocampal Synaptic Plasticity
por: Patten, Anna R., et al.
Publicado: (2013)

Mitochondrial Dysfunction, Neurogenesis, and Epigenetics: Putative Implications for Amyotrophic Lateral Sclerosis Neurodegeneration and Treatment
por: Calió, Michele Longoni, et al.
Publicado: (2020)

Regulation of one-carbon metabolism may open new avenues to slow down the initiation and progression of Huntington’s disease
por: Xie, Jiahua, et al.
Publicado: (2023)

New Avenues of Heme Synthesis Regulation
por: Medlock, Amy E., et al.
Publicado: (2022)

Dexmedetomidine: New avenues
por: Grewal, Anju
Publicado: (2011)

Microbiome insights open new avenues to treat HPV
por: McDermott, Amy
Publicado: (2023)

New Avenues in Pharmaceutical Education
por: Udupa, N.
Publicado: (2011)

New Avenues in Management of Trichotillomania
por: Chawla, Omna, et al.
Publicado: (2013)

New avenues in cardio-oncology
por: Sala, Valentina, et al.
Publicado: (2019)

Hemifacial hypertrophy: Exploring new avenues of treatment modalities
por: Nandimath, Santosh Ashok, et al.
Publicado: (2016)

A new avenue for treatment of chronic hand eczema
por: Schuttelaar, Marie L.A.
Publicado: (2022)

Molecular Basis Underlying the Therapeutic Potential of Vitamin D for the Treatment of Depression and Anxiety
por: Kouba, Bruna R., et al.
Publicado: (2022)

Gangliosides: Treatment Avenues in Neurodegenerative Disease
por: Magistretti, Pierre J., et al.
Publicado: (2019)

Nanobodies: new avenue to treat kidney disease
por: Wanner, Nicola, et al.
Publicado: (2021)

Senescence and the SASP: many therapeutic avenues
por: Birch, Jodie, et al.
Publicado: (2020)

New Avenues for Nanoparticle-Related Therapies
por: Zhao, Michael, et al.
Publicado: (2018)

New Avenues for Phosphodiesterase Inhibitors in Asthma
por: Matera, Maria Gabriella, et al.
Publicado: (2021)

New avenues for mechanochemistry in zeolite science
por: Rainer, Daniel N., et al.
Publicado: (2021)

Swine enteric colibacillosis: Current treatment avenues and future directions
por: Castro, Joana, et al.
Publicado: (2022)

Novel astrocyte targets: New Avenues for the Therapeutic Treatment of Epilepsy
por: Crunelli, Vincenzo, et al.
Publicado: (2015)

NLRP3 Inflammasome: From Pathophysiology to Therapeutic Target in Major Depressive Disorder
por: Kouba, Bruna R., et al.
Publicado: (2022)

New avenues in the medical treatment of Cushing’s disease: corticotroph tumor targeted therapy
por: Fleseriu, Maria, et al.
Publicado: (2013)

Periodontal disease and its prevention, by traditional and new avenues
por: Mann, Jonathan, et al.
Publicado: (2020)

New Promising Therapeutic Avenues of Curcumin in Brain Diseases
por: Benameur, Tarek, et al.
Publicado: (2021)

Inflammation in Health and Disease: New Insights and Therapeutic Avenues
por: Scotece, Morena, et al.
Publicado: (2022)

Senescence and aging: Causes, consequences, and therapeutic avenues
por: McHugh, Domhnall, et al.
Publicado: (2018)

Avenues of Death
Publicado: (1861)

Avenues of Death
Publicado: (1880)

Avenues of Death
Publicado: (1877)

Ventricular Arrhythmias in Ischemic Cardiomyopathy—New Avenues for Mechanism-Guided Treatment
por: Amoni, Matthew, et al.
Publicado: (2021)

New Avenues Towards Prevention and Treatment of Mucositis Induced by Cancer Therapies
por: Zambrano, Angela R., et al.
Publicado: (2021)

New avenues for matter-wave-enhanced spectroscopy
por: Rodewald, Jonas, et al.
Publicado: (2016)

Glycosphingolipids and Infection. Potential New Therapeutic Avenues
por: Aerts, Johannes M. F. G., et al.
Publicado: (2019)

Viruses with U-DNA: New Avenues for Biotechnology
por: Nagy, Kinga K., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uqd6qsvm53qd73p7lkd2m5im3t